title: Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging.
abstract: Magnetic resonance (MR) imaging was performed in 26 patients with Ewing's sarcoma of bone preceding and following neoadjuvant chemotherapy, to assess tumour response non-invasively prior to surgery. T1- and T2-weighted spin echo images were obtained. Changes including intra- and extramedullary signal intensities, tumour demarcation, tumour volume and the appearance of residual extramedullary tumour were compared with histopathology of the resected specimens. Reduction of tumour volume was significantly higher in good responders. Other single parameters did not correlate with histologic tumour response. However, when several MR parameters summarized in a classification system were combined, a positive correlation with histopathologic response was found. A limited decrease of tumour volume (< 25%) and/or residual soft tissue mass following chemotherapy correlated with a poor response. An inhomogeneous, well-defined cuff of abnormal tissue encircling the bone and/or radiological disappearance of the soft tissue tumour component following chemotherapy correlated with good response. Twenty-three out of 26 patients were correctly classified by MR as good or poor responders. Minimal residual disease (< 10% of the entire tumour volume), observed histologically, could not be identified with MR imaging. Tumour volume reduction and residual extramedullary tumour, rather than changes of signal intensity, are major features for evaluating the response to chemotherapy in Ewing's sarcoma.
authors: Department of Diagnostic Radiology, University Hospital, Leiden, The Netherlands.
authors: H J
authors: HJ
authors: van der Woude
authors: J L
authors: JL
authors: Bloem
authors: H C
authors: HC
authors: Holscher
authors: M A
authors: MA
authors: Nooy
authors: A H
authors: AH
authors: Taminiau
authors: J
authors: J
authors: Hermans
authors: T H
authors: TH
authors: Falke
authors: P C
authors: PC
authors: Hogendoorn
mesh_terms: D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D012512:Sarcoma, Ewing / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology